BrainStorm Cell Therapeutics has received a notice of allowance from the US Patent Office for its ‘Mesenchymal Stem Cells for the Treatment of CNS Diseases’ (serial number 12/994,761) patent application. This patent relates to ...
Tags: Cell Technology Patent, Medicine
Harvard stem cells scientists at Brigham and Women's Hospital and MIT can now engineer cells that are more easily controlled following transplantation, potentially making cell therapies, hundreds of which are currently in clinical trials ...
Tags: stem cells
A patient's own bone marrow stem cells might someday be used to treat multidrug-resistant tuberculosis, a new study suggests. The phase 1 study to assess the safety of the treatment included 30 patients, aged 21 to 65, with ...
Johnson & Johnson's Janssen Biotech Inc. is showing interest in stem cell therapy delivered to the heart via a catheter. Janssen is providing an upfront payment of $12.5 million related to Capricor Therapeutics Inc.'s CAP-1002 therapy ...
Tags: Janssen, Catheter, Stem Cell Tech
Cell culture and gene modulation technology, as well as magnetic beads used protein analysis and medical diagnostics, are included in GE's $1.06 billion acquisition of life science business lines from Thermo Fisher Scientific. GE ...
Tags: Life Sciences Technology, Health, Medicine
Cord Blood America, Inc. (www.cordblood-america.com) (OTC Bulletin Board: CBAI) ("CBAI" or the "Company") today announced it has achieved AABB accreditation for cell therapy activity associated with cord blood processing, storage and ...
Tags: Cord Blood America, AABB accreditation, cell therapy activity
One of the great mysteries surrounding the field of stem cell therapy is how the cells are distributed after being injected. Do they disperse evenly? Do they travel to the area where they're needed? And how long do they stick around? ...
Tags: stem cell, scintigraphy, stem cell therapy, mesenchymal stem cell
A demonstration in Rome by supporters of stem-cell therapy snarled traffic and forced the lower of house of Parliament to shut down Monday. The protesters claim a potential therapy involving the removal of bone-marrow stem cells from a ...
Tags: stem-cell, treatment, demonstration, Rome, snarls, traffic
The European Commission has granted orphan drug designation to BrainStorm Cell Therapeutics’ stem cell therapy NurOwn to treat Amyotrophic Lateral Sclerosis (ALS), also known as Lou Gehrig's Disease. NurOwn consists of autologous ...
Tags: Orphan Drug, Medicine
Roche has announced that the Canadian Health Authority has approved the use of its PCR based mycoplasma detection test MycoTOOL for release testing of one of its biological products. Accepted by the FDA at the end of 2012, the test can ...
Tags: Roche, Health Authority
BioRestorative Therapies (BRT) has signed a consulting agreement with Dexterity, to develop and manufacture BRT's proprietary therapeutic delivery device for its intervertebral disc stem cell therapy program, brtxDISC (Disc Implanted Stem ...
Adaptimmune has partnered with a North American clinical data management company SCiAN Services for SCiAN's EDCPRO solution. Under the collaboration, SCiAN will deliver a comprehensive systems and services solution for Web-based data ...
The Office of the Chief Scientist (OCS) in Israel has awarded $3m NIS grant to support BrainStorm Cell Therapeutics' research and development program for stem cell therapy candidate, NurOwn. NurOwn is an autologous, adult stem cell ...
Tags: stem cell therapy technology, Cell Therapeutics, therapy technology
Cytori Therapeutics, a developer of cell therapies based on autologous adipose-derived regenerative cells (ADRCs), has obtained Russian approval for its Celution 800 system. The Celution system and its related products including ADRCs ...
Tags: cell therapy, Celution 800 system, clinical product, clinical research
Aequus BioPharma,a subsidiary of Cell Therapeutics,has named Ronald Berenson as the company's new president and CEO. Prior to joining the company,Berenson served as president and CEO at HemaQuest Pharmaceuticals and as ...
Tags: Aequus BioPharma, Cell Therapeutics, CEO, Ronald Berenson